Back

Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 5 Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Eue-Keun Choi

Seoul National University Hospital, Seoul (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
Professor G. Lip (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Professor M. Blomstrom-Lundqvist (Orebro, SE)
Abstract Slides
Presentation thumbnail
Professor P. Kirchhof (Hamburg, DE)
Abstract
Presentation thumbnail
Professor Z. Motovska (Prague, CZ)
Abstract Slides
Presentation thumbnail
Doctor T. Chao (Taipei, TW)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 5

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources